[English] 日本語
Yorodumi
- PDB-8g8x: X-ray co-crystal structure of compound 27 in with complex JAK2 -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 8g8x
TitleX-ray co-crystal structure of compound 27 in with complex JAK2
ComponentsTyrosine-protein kinase JAK2
KeywordsTRANSFERASE/Inhibitor / inhibitor / JAK2 / kinase / TRANSFERASE / TRANSFERASE-Inhibitor complex
Function / homology
Function and homology information


interleukin-35-mediated signaling pathway / intracellular mineralocorticoid receptor signaling pathway / histone H3Y41 kinase activity / activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway / positive regulation of growth factor dependent skeletal muscle satellite cell proliferation / symbiont-induced defense-related programmed cell death / mammary gland epithelium development / regulation of postsynapse to nucleus signaling pathway / positive regulation of growth hormone receptor signaling pathway / Signaling by Erythropoietin ...interleukin-35-mediated signaling pathway / intracellular mineralocorticoid receptor signaling pathway / histone H3Y41 kinase activity / activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway / positive regulation of growth factor dependent skeletal muscle satellite cell proliferation / symbiont-induced defense-related programmed cell death / mammary gland epithelium development / regulation of postsynapse to nucleus signaling pathway / positive regulation of growth hormone receptor signaling pathway / Signaling by Erythropoietin / granulocyte macrophage colony-stimulating factor receptor complex / granulocyte-macrophage colony-stimulating factor signaling pathway / interleukin-12 receptor binding / post-embryonic hemopoiesis / collagen-activated signaling pathway / Erythropoietin activates STAT5 / Erythropoietin activates Phospholipase C gamma (PLCG) / interleukin-5-mediated signaling pathway / response to interleukin-12 / positive regulation of leukocyte proliferation / interleukin-12 receptor complex / activation of Janus kinase activity / interleukin-23 receptor complex / positive regulation of platelet aggregation / tyrosine phosphorylation of STAT protein / Interleukin-23 signaling / positive regulation of MHC class II biosynthetic process / positive regulation of T-helper 17 type immune response / positive regulation of platelet activation / type 1 angiotensin receptor binding / positive regulation of NK T cell proliferation / interleukin-12-mediated signaling pathway / interleukin-3-mediated signaling pathway / regulation of nitric oxide biosynthetic process / acetylcholine receptor binding / cellular response to interleukin-3 / Signaling by Leptin / Interleukin-12 signaling / positive regulation of signaling receptor activity / Interleukin-35 Signalling / Interleukin-27 signaling / IL-6-type cytokine receptor ligand interactions / positive regulation of cell-substrate adhesion / positive regulation of epithelial cell apoptotic process / response to hydroperoxide / regulation of receptor signaling pathway via JAK-STAT / growth hormone receptor binding / positive regulation of natural killer cell proliferation / axon regeneration / growth hormone receptor signaling pathway / peptide hormone receptor binding / negative regulation of cardiac muscle cell apoptotic process / intrinsic apoptotic signaling pathway in response to oxidative stress / extrinsic component of plasma membrane / IFNG signaling activates MAPKs / Interleukin-20 family signaling / interleukin-6-mediated signaling pathway / Erythropoietin activates Phosphoinositide-3-kinase (PI3K) / negative regulation of cell-cell adhesion / Interleukin-6 signaling / enzyme-linked receptor protein signaling pathway / Prolactin receptor signaling / positive regulation of interleukin-17 production / MAPK3 (ERK1) activation / negative regulation of DNA binding / response to amine / positive regulation of nitric-oxide synthase biosynthetic process / MAPK1 (ERK2) activation / mesoderm development / positive regulation of SMAD protein signal transduction / cell surface receptor signaling pathway via JAK-STAT / platelet-derived growth factor receptor signaling pathway / insulin receptor substrate binding / Interleukin-3, Interleukin-5 and GM-CSF signaling / growth hormone receptor signaling pathway via JAK-STAT / response to tumor necrosis factor / Interleukin receptor SHC signaling / phosphatidylinositol 3-kinase binding / type II interferon-mediated signaling pathway / Regulation of IFNG signaling / Erythropoietin activates RAS / Growth hormone receptor signaling / extrinsic apoptotic signaling pathway / positive regulation of T cell proliferation / Signaling by CSF3 (G-CSF) / positive regulation of tyrosine phosphorylation of STAT protein / extrinsic component of cytoplasmic side of plasma membrane / positive regulation of vascular associated smooth muscle cell proliferation / tumor necrosis factor-mediated signaling pathway / actin filament polymerization / SH2 domain binding / erythrocyte differentiation / cellular response to dexamethasone stimulus / post-translational protein modification / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / positive regulation of interleukin-1 beta production / caveola / positive regulation of apoptotic signaling pathway / endosome lumen / positive regulation of cell differentiation
Similarity search - Function
Tyrosine-protein kinase, non-receptor Jak2 / Janus kinase 2, pseudokinase domain / Janus kinase 2, catalytic domain / Tyrosine-protein kinase JAK2, SH2 domain / JAK2, FERM domain C-lobe / Tyrosine-protein kinase, non-receptor Jak/Tyk2 / JAK, FERM F2 lobe domain / FERM F1 lobe ubiquitin-like domain / JAK1-3/TYK2, pleckstrin homology-like domain / Jak1 pleckstrin homology-like domain ...Tyrosine-protein kinase, non-receptor Jak2 / Janus kinase 2, pseudokinase domain / Janus kinase 2, catalytic domain / Tyrosine-protein kinase JAK2, SH2 domain / JAK2, FERM domain C-lobe / Tyrosine-protein kinase, non-receptor Jak/Tyk2 / JAK, FERM F2 lobe domain / FERM F1 lobe ubiquitin-like domain / JAK1-3/TYK2, pleckstrin homology-like domain / Jak1 pleckstrin homology-like domain / FERM F2 acyl-CoA binding protein-like domain / FERM F1 ubiquitin-like domain / FERM central domain / FERM superfamily, second domain / FERM domain / FERM domain profile. / Band 4.1 domain / Band 4.1 homologues / SH2 domain / Src homology 2 (SH2) domain profile. / Src homology 2 domains / SH2 domain / SH2 domain superfamily / Tyrosine-protein kinase, catalytic domain / Tyrosine kinase, catalytic domain / Tyrosine protein kinases specific active-site signature. / PH-like domain superfamily / Tyrosine-protein kinase, active site / Protein tyrosine and serine/threonine kinase / Serine-threonine/tyrosine-protein kinase, catalytic domain / Protein kinase, ATP binding site / Protein kinases ATP-binding region signature. / Protein kinase domain profile. / Protein kinase domain / Protein kinase-like domain superfamily
Similarity search - Domain/homology
Chem-YT8 / Tyrosine-protein kinase JAK2
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.97 Å
AuthorsMiller, S.T. / Ellis, D.A.
Funding support1items
OrganizationGrant numberCountry
Not funded
CitationJournal: J.Med.Chem. / Year: 2023
Title: Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase ...Title: Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility.
Authors: Gordhan, H.M. / Miller, S.T. / Clancy, D.C. / Ina, M. / McDougal, A.V. / Cutno, D.K. / Brown, R.V. / Lichorowic, C.L. / Sturdivant, J.M. / Vick, K.A. / Williams, S.S. / deLong, M.A. / White, ...Authors: Gordhan, H.M. / Miller, S.T. / Clancy, D.C. / Ina, M. / McDougal, A.V. / Cutno, D.K. / Brown, R.V. / Lichorowic, C.L. / Sturdivant, J.M. / Vick, K.A. / Williams, S.S. / deLong, M.A. / White, J.C. / Kopczynski, C.C. / Ellis, D.A.
History
DepositionFeb 20, 2023Deposition site: RCSB / Processing site: RCSB
Revision 1.0Jun 21, 2023Provider: repository / Type: Initial release
Revision 1.1Jul 26, 2023Group: Database references / Category: citation / citation_author
Item: _citation.journal_volume / _citation.page_first ..._citation.journal_volume / _citation.page_first / _citation.page_last / _citation_author.identifier_ORCID
Revision 1.2Oct 25, 2023Group: Data collection / Category: chem_comp_atom / chem_comp_bond
Revision 1.3Nov 15, 2023Group: Data collection / Category: chem_comp_atom / chem_comp_bond / Item: _chem_comp_atom.atom_id / _chem_comp_bond.atom_id_2

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Tyrosine-protein kinase JAK2
B: Tyrosine-protein kinase JAK2
hetero molecules


Theoretical massNumber of molelcules
Total (without water)75,5524
Polymers74,9172
Non-polymers6352
Water3,783210
1


  • Idetical with deposited unit
  • defined by author
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Unit cell
Length a, b, c (Å)36.650, 172.560, 52.480
Angle α, β, γ (deg.)90.00, 110.60, 90.00
Int Tables number4
Space group name H-MP1211

-
Components

#1: Protein Tyrosine-protein kinase JAK2 / Janus kinase 2 / JAK-2


Mass: 37458.535 Da / Num. of mol.: 2 / Mutation: M1073S, F1076T
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: JAK2 / Production host: Spodoptera frugiperda (fall armyworm)
References: UniProt: O60674, non-specific protein-tyrosine kinase
#2: Chemical ChemComp-YT8 / 3-cyclopropyl-1-{5-methyl-2-[(3-methyl-1,2-thiazol-5-yl)amino]pyrimidin-4-yl}azetidin-3-ol


Mass: 317.409 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: C15H19N5OS / Feature type: SUBJECT OF INVESTIGATION
#3: Water ChemComp-HOH / water / Water


Mass: 18.015 Da / Num. of mol.: 210 / Source method: isolated from a natural source / Formula: H2O
Has ligand of interestY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.07 Å3/Da / Density % sol: 40.68 %
Crystal growTemperature: 293 K / Method: vapor diffusion, hanging drop / Details: PEG 3350, ammonium acetate, HEPES

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: Diamond / Beamline: I03 / Wavelength: 0.9763 Å
DetectorType: DECTRIS EIGER2 XE 16M / Detector: PIXEL / Date: Dec 11, 2020
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.9763 Å / Relative weight: 1
ReflectionResolution: 1.97→43.14 Å / Num. obs: 42978 / % possible obs: 100 % / Redundancy: 7 % / Rmerge(I) obs: 0.122 / Rpim(I) all: 0.049 / Net I/σ(I): 12.2
Reflection shellResolution: 1.97→2.02 Å / Rmerge(I) obs: 1.167 / Mean I/σ(I) obs: 1.7 / Num. unique obs: 3082 / Rpim(I) all: 0.465

-
Processing

Software
NameVersionClassification
REFMAC5refinement
xia2data reduction
XDSdata scaling
PHASERphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 3IOK
Resolution: 1.97→42.73 Å / Cor.coef. Fo:Fc: 0.953 / Cor.coef. Fo:Fc free: 0.934 / SU B: 9.314 / SU ML: 0.13 / Cross valid method: THROUGHOUT / ESU R: 0.187 / ESU R Free: 0.164 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
RfactorNum. reflection% reflectionSelection details
Rfree0.23569 2158 5 %RANDOM
Rwork0.19457 ---
obs0.19655 40778 99.95 %-
Solvent computationIon probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: BABINET MODEL WITH MASK
Displacement parametersBiso mean: 37.676 Å2
Baniso -1Baniso -2Baniso -3
1--0 Å20 Å2-0.57 Å2
2--1.43 Å20 Å2
3----0.78 Å2
Refinement stepCycle: 1 / Resolution: 1.97→42.73 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms4636 0 44 210 4890
Refine LS restraints
Refine-IDTypeDev idealDev ideal targetNumber
X-RAY DIFFRACTIONr_bond_refined_d0.0130.0134787
X-RAY DIFFRACTIONr_bond_other_d0.0010.0174545
X-RAY DIFFRACTIONr_angle_refined_deg1.8761.6566462
X-RAY DIFFRACTIONr_angle_other_deg1.4351.58610475
X-RAY DIFFRACTIONr_dihedral_angle_1_deg6.7695557
X-RAY DIFFRACTIONr_dihedral_angle_2_deg34.05122.259270
X-RAY DIFFRACTIONr_dihedral_angle_3_deg17.60415882
X-RAY DIFFRACTIONr_dihedral_angle_4_deg20.6891534
X-RAY DIFFRACTIONr_chiral_restr0.0960.2593
X-RAY DIFFRACTIONr_gen_planes_refined0.010.025311
X-RAY DIFFRACTIONr_gen_planes_other0.0010.021109
X-RAY DIFFRACTIONr_nbd_refined
X-RAY DIFFRACTIONr_nbd_other
X-RAY DIFFRACTIONr_nbtor_refined
X-RAY DIFFRACTIONr_nbtor_other
X-RAY DIFFRACTIONr_xyhbond_nbd_refined
X-RAY DIFFRACTIONr_xyhbond_nbd_other
X-RAY DIFFRACTIONr_metal_ion_refined
X-RAY DIFFRACTIONr_metal_ion_other
X-RAY DIFFRACTIONr_symmetry_vdw_refined
X-RAY DIFFRACTIONr_symmetry_vdw_other
X-RAY DIFFRACTIONr_symmetry_hbond_refined
X-RAY DIFFRACTIONr_symmetry_hbond_other
X-RAY DIFFRACTIONr_symmetry_metal_ion_refined
X-RAY DIFFRACTIONr_symmetry_metal_ion_other
X-RAY DIFFRACTIONr_mcbond_it2.0882.5852243
X-RAY DIFFRACTIONr_mcbond_other2.0832.5852242
X-RAY DIFFRACTIONr_mcangle_it3.2073.8562792
X-RAY DIFFRACTIONr_mcangle_other3.2073.8572793
X-RAY DIFFRACTIONr_scbond_it2.7152.9942544
X-RAY DIFFRACTIONr_scbond_other2.7152.9942544
X-RAY DIFFRACTIONr_scangle_it
X-RAY DIFFRACTIONr_scangle_other4.3284.3523660
X-RAY DIFFRACTIONr_long_range_B_refined6.949.44320135
X-RAY DIFFRACTIONr_long_range_B_other6.8649.33220003
X-RAY DIFFRACTIONr_rigid_bond_restr
X-RAY DIFFRACTIONr_sphericity_free
X-RAY DIFFRACTIONr_sphericity_bonded
Refine LS restraints NCS

Ens-ID: 1 / Number: 9316 / Refine-ID: X-RAY DIFFRACTION / Type: interatomic distance / Rms dev position: 0.09 Å / Weight position: 0.05

Dom-IDAuth asym-ID
1A
2B
LS refinement shellResolution: 1.97→2.021 Å / Total num. of bins used: 20
RfactorNum. reflection% reflection
Rfree0.323 176 -
Rwork0.268 3025 -
obs--99.75 %
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL112)L122)L132)L222)L232)L332)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T112)T122)T132)T222)T232)T332)Origin x (Å)Origin y (Å)Origin z (Å)
13.25150.4877-1.4770.8075-0.76314.7658-0.0465-0.2255-0.0282-0.0065-0.0448-0.0726-0.0756-0.01770.09130.08580.0627-0.05360.0624-0.02530.061817.54930.07138.545
210.29-0.02870.25327.82220.3020.41790.15680.34630.2404-0.1522-0.0917-0.6602-0.07030.0186-0.06510.1097-0.02210.00760.02310.00550.153721.03338.73121.042
31.0734-0.29230.31641.47380.05661.6623-0.1204-0.18280.20640.13870.0724-0.0093-0.1224-0.03590.0480.05630.0323-0.04440.112-0.03030.08979.77632.63229.611
40.8147-0.34130.13093.97040.67260.2299-0.0070.0534-0.0170.30260.02170.00030.0991-0.0442-0.01470.0804-0.012-0.00270.07540.02160.06237.7249.34624.405
51.2582-0.61040.23160.8134-0.60431.7454-0.0434-0.0030.01990.0096-0.0072-0.04560.0262-0.13370.05050.0701-0.0075-0.03040.0368-0.00960.09936.16524.31318.939
61.31670.24070.19811.3634-0.96082.1084-0.0171-0.06930.17510.0818-0.04740.0127-0.30770.13760.06450.0931-0.0019-0.00970.0362-0.01070.118710.56532.54312.743
70.2603-0.15940.09190.8513-0.23370.52830.0078-0.0125-0.0116-0.0299-0.026-0.0481-0.03890.0070.01820.0696-0.0146-0.01110.07520.00570.121516.08317.0279.338
85.68591.06912.735712.7780.14092.2641-0.04910.08860.0199-0.037-0.1665-0.471-0.06550.1780.21570.039-0.00850.03070.15690.03670.098328.74818.3620.995
90.7616-0.2151-0.20650.6424-0.47951.05310.03060.0881-0.0552-0.0798-0.02330.07360.00930.0348-0.00730.0633-0.0121-0.02830.0737-0.00630.09649.70913.3542.563
103.72372.04150.49155.0555-3.72724.1230.0562-0.3135-0.0624-0.04540.1720.18040.0844-0.389-0.22810.0029-0.0129-0.01260.1530.01330.1222-4.34714.29712.363
113.2505-0.10941.70662.80360.46983.92740.04040.1417-0.0257-0.03870.0504-0.0916-0.01920.1771-0.09070.097-0.01460.05690.0303-0.00750.045118.103-29.84-7.568
122.5613-1.96275.25881.717-4.178710.92870.09760.23050.097-0.0763-0.2406-0.06890.19570.51340.1430.1078-0.00020.03380.09380.01570.106516.672-29.234-7.58
131.299-2.2916-3.05594.9447.631112.7604-0.1542-0.1376-0.40050.20870.30270.27050.17260.446-0.14850.19730.13460.14990.22020.10570.376924.725-39.8558.968
143.5696-1.30180.51961.3247-0.28222.66150.01470.0687-0.16140.1287-0.14020.05810.40160.02770.12550.1236-0.01240.04420.03170.00860.08538.841-34.67.177
150.315-0.5422-0.43513.68171.68051.5162-0.04190.0123-0.0008-0.03860.1384-0.18720.05130.0812-0.09650.0772-0.00230.0430.0655-0.00360.085912.876-24.120.422
160.38951.36370.11827.8459-0.91350.631-0.05750.01330.0125-0.06630.05980.0582-0.054-0.0342-0.00230.051-0.00030.01680.10230.01570.10041.838-14.97710.812
170.3102-0.00320.36572.1243-1.35952.69630.0490.0559-0.0566-0.01020.0485-0.00110.07750.0364-0.09750.05650.01720.02890.03680.00520.10668.848-27.81714.261
180.5960.41320.0981.4007-0.68051.30620.00070.0046-0.02990.0445-0.04-0.12040.00460.08650.03930.04650.01910.01560.07140.00960.112716.342-16.7321.88
1915.24244.1069-9.600713.8636-0.65746.3428-0.3022-0.0775-0.3781-0.25340.04130.00130.17670.07570.26080.07750.02330.00520.13070.03070.060728.033-19.71928.882
200.8802-0.0014-0.09840.3758-0.37321.21620.0335-0.00510.04860.10960.03410.0559-0.0807-0.0873-0.06750.06040.01930.02170.08280.00270.10935.698-13.37625.364
Refinement TLS group
IDRefine-IDRefine TLS-IDAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1A842 - 884
2X-RAY DIFFRACTION2A885 - 898
3X-RAY DIFFRACTION3A899 - 933
4X-RAY DIFFRACTION4A934 - 959
5X-RAY DIFFRACTION5A960 - 988
6X-RAY DIFFRACTION6A989 - 1012
7X-RAY DIFFRACTION7A1013 - 1065
8X-RAY DIFFRACTION8A1066 - 1077
9X-RAY DIFFRACTION9A1078 - 1114
10X-RAY DIFFRACTION10A1115 - 1130
11X-RAY DIFFRACTION11B842 - 871
12X-RAY DIFFRACTION12B872 - 885
13X-RAY DIFFRACTION13B886 - 893
14X-RAY DIFFRACTION14B894 - 909
15X-RAY DIFFRACTION15B910 - 946
16X-RAY DIFFRACTION16B947 - 969
17X-RAY DIFFRACTION17B970 - 1009
18X-RAY DIFFRACTION18B1010 - 1071
19X-RAY DIFFRACTION19B1072 - 1076
20X-RAY DIFFRACTION20B1077 - 1130

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more